| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.069.469 | 13.298 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 1.072.283 | 13.538 | 60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.030.034 | 9.079 | 2.660 | 612 | 321 | 859 | 679 | 682 | 308 | 408 |
| Gross Profit/Loss - EUR | 42.249 | 4.459 | -2.600 | -612 | -321 | -859 | -679 | -682 | -308 | -408 |
| Net Profit/Loss - EUR | 35.497 | 3.745 | -2.602 | -612 | -321 | -859 | -679 | -682 | -308 | -408 |
| Employees | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Avana Medical Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 512.390 | 45.770 | 43.983 | 43.175 | 42.339 | 41.454 | 40.494 | 40.620 | 40.497 | 40.270 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 488.735 | 43.456 | 42.780 | 41.995 | 41.182 | 40.401 | 39.505 | 39.628 | 39.508 | 39.287 |
| Cash | 23.654 | 2.315 | 1.202 | 1.180 | 1.157 | 1.053 | 989 | 992 | 989 | 983 |
| Shareholders Funds | 35.721 | 39.147 | 35.883 | 34.612 | 33.621 | 32.125 | 30.734 | 30.147 | 29.747 | 29.173 |
| Social Capital | 225 | 267 | 263 | 258 | 253 | 248 | 243 | 243 | 243 | 241 |
| Debts | 476.668 | 6.623 | 8.248 | 8.712 | 8.894 | 9.330 | 9.939 | 10.638 | 10.965 | 11.097 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Avana Medical Consult Srl